Psoriasis and Keloids

Summary:

Keloids is found among people with Psoriasis, especially for people who are female, 60+ old.

The study analyzes which people have Keloids with Psoriasis. It is created by eHealthMe based on reports of 20 people who have Psoriasis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Psoriasis?

Psoriasis (immune-mediated disease that affects the skin) is found to be associated with 1,476 drugs and 1,694 conditions by eHealthMe. Check the latest studies of Psoriasis.

What is Keloids?

Keloids (overgrown scars left from skin injuries) is found to be associated with 103 drugs and 496 conditions by eHealthMe. Check the latest studies of Keloids.

On Jul, 05, 2026

20 people who have Psoriasis and Keloids are studied.

Would you have Keloids when you have Psoriasis?

Gender of people who have Psoriasis and experienced Keloids *:

female: 78.95 %
male: 21.05 %

Age of people who have Psoriasis and experienced Keloids *:

Common co-existing conditions for these people *:

Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 3 people, 15.00%
Sleep Walking (walking during sleep): 1 person, 5.00%
Pyoderma Gangrenosum (ulcerating condition of skin that results in heaped borders with a typical appearance): 1 person, 5.00%
Pustular Psoriasis (raised bumps on the skin that are filled with pus): 1 person, 5.00%
Migraine (headache): 1 person, 5.00%
Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 1 person, 5.00%
Irritable Bowel Syndrome: 1 person, 5.00%
Depression: 1 person, 5.00%

Common drugs taken by these people *:

Cosentyx: 7 people, 35.00%
Humira: 3 people, 15.00%
Skyrizi: 3 people, 15.00%
Elidel: 2 people, 10.00%
Fluoxetine: 2 people, 10.00%
Triamcinolone Acetonide: 2 people, 10.00%
Stelara: 2 people, 10.00%
Methotrexate: 2 people, 10.00%
Enbrel: 2 people, 10.00%
Geodon: 1 person, 5.00%

Common symptoms for these people *:

Drug Ineffective: 8 people, 40.00%
Joint Pain: 7 people, 35.00%
Skin Exfoliation (removal of the oldest dead skin cells): 4 people, 20.00%
Rashes (redness): 3 people, 15.00%
Headache (pain in head): 3 people, 15.00%
Injection Site Pain: 2 people, 10.00%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 10.00%
Papule: 2 people, 10.00%
Pain In Extremity: 2 people, 10.00%
Memory Loss: 2 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Keloids?

- Check whether Keloids is associated with a drug or a condition

Related publications that referenced our studies

Mohagheghi MA, Omranipur R, Ensani F, Ghannadan A, Shahriaran S, Samiee F, Sedighi Z, "A Case of Advanced Unicentric Retroperitoneal Castleman's Disease, Associated With Psoriasis", Acta Medica Iranica, 2017 May .
Chiriac A, Brzezinski P, Stolnicu S, Podoleanu C, Moldovan C, Molnar C, Taranu T, "Eosinophilia–A rare possible adverse reaction during anti-tumor necrosis factor-alpha therapy for psoriasis", Journal of Dermatological Treatment, 2016 Mar .
Malisiewicz B, Murer C, Schmid JP, French LE, Schmid-Grendelmeier P, Navarini AA, "Eosinophilia during psoriasis treatment with TNF antagonists", Dermatology, 2013 Jan .
Mohagheghi MA, Omranipur R, Ensani F, Ghannadan A, Shahriaran S, Samiee F, Sedighi Z, "A Case of Advanced Unicentric Retroperitoneal Castleman's Disease, Associated With Psoriasis", Acta Medica Iranica, 2017 May .
Chiriac A, Brzezinski P, Stolnicu S, Podoleanu C, Moldovan C, Molnar C, Taranu T, "Eosinophilia–A rare possible adverse reaction during anti-tumor necrosis factor-alpha therapy for psoriasis", Journal of Dermatological Treatment, 2016 Mar .
Malisiewicz B, Murer C, Schmid JP, French LE, Schmid-Grendelmeier P, Navarini AA, "Eosinophilia during psoriasis treatment with TNF antagonists", Dermatology, 2013 Jan .

Related studies:

Treatments, associated drugs and conditions:

Psoriasis (508,163 reports)
Keloids (1,142 reports)

All the drugs that are associated with Keloids:

Keloids (103 drugs)

All the conditions that are associated with Keloids:

Keloids (496 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Keloids and Psoriasis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.